Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Aragon Pharmaceuticals Inc.
Headquarters: San Diego, CA, United States of America
Website: N/A
Year Founded: 2009
Status: Acquired
BioCentury | Oct 30, 2020
Product Development
José Baselga on how new modalities and biomarkers are shaping AZ’s oncology strategy
AZ’s oncology R&D head identifies priority technologies, targets and combination strategies
BioCentury | Aug 3, 2020
Finance
After raising crossover-heavy $70M round, p53 play PMV likely one of the next preclinical IPOs
BioCentury | Apr 4, 2020
Finance
Steady as venBio goes
venBio is staying the course with relatively small $394 million fund even as it moves away from strategic investors
BioCentury | May 2, 2016
Finance
Pillars of strength
The Column Group looks to make bigger, but fewer, bets with its new fund
BioCentury | Dec 7, 2015
Finance
Hard to resist
Why investors in Aragon, Seragon are coming back for thirds with Oric
BioCentury | Aug 10, 2015
Finance
Venturing into diabetes
Why Metacrine's investors are funding a chronic disease company
Items per page:
1 - 10 of 57